Stock of the Day

STAAR Surgical (STAA)

$16.87

+$0.02 (+0.1%)

Market Cap: $830.30M

About STAAR Surgical

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye.

The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Recent News

• What To Expect From Staar Surgical Co (STAA) Q4 2024 Earnings (gurufocus.com)
• STAA Investors Have Opportunity to Join STAAR Surgical Company Fraud Investigation with the Schall Law Firm (prnewswire.com)
• INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of STAAR Surgical Company. - STAA (prnewswire.com)
• STAAR Surgical Company (NASDAQ:STAA) Q4 2024 Earnings Call Transcript (insidermonkey.com)
• Staar Surgical (STAA) was downgraded to a Hold Rating at William Blair (markets.businessinsider.com)